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Abstract. 
 
U2 small nuclear (sn)RNA contains a large
number of posttranscriptionally modiﬁed nucleotides,
 
including a 5
 
9 
 
trimethylated guanosine cap, 13 pseudo-
 
uridines, and 10 2
 
9
 
-
 
O
 
-methylated residues. Using 
 
Xeno-
pus
 
 oocytes, we demonstrated previously that at least
some of these modiﬁed nucleotides are essential for bio-
genesis of a functional snRNP. Here we address the sub-
cellular site of U2 internal modiﬁcation. Upon injection
into the cytoplasm of oocytes, G-capped U2 that is
transported to the nucleus becomes modiﬁed, whereas
 
A-capped U2 that remains in the cytoplasm is not modi-
ﬁed. Furthermore, by injecting U2 RNA into isolated
nuclei or enucleated oocytes, we observe that U2 internal
modiﬁcations occur exclusively in the nucleus. Analysis of
the intranuclear localization of ﬂuorescently labeled
 
RNAs shows that injected wild-type U2 becomes lo-
calized to nucleoli and Cajal bodies. Both internal
modiﬁcation and nucleolar localization of U2 are de-
pendent on the Sm binding site. An Sm-mutant U2 is
targeted only to Cajal bodies. The Sm binding site can
be replaced by a nucleolar localization signal derived
from small nucleolar RNAs (the box C/D motif), resulting
in rescue of internal modiﬁcation as well as nucleolar
localization. Analysis of additional chimeric U2 RNAs
reveals a correlation between internal modiﬁcation and
nucleolar localization. Together, our results suggest that
U2 internal modiﬁcation occurs within the nucleolus.
Key words: snRNP • Sm binding site • modiﬁed nu-
cleotide • snoRNA • localization
 
Introduction
 
The spliceosomal small nuclear (sn)
 
1
 
RNAs (U1, U2, U4,
U5, and U6), which are essential for pre-mRNA splicing,
are all posttranscriptionally modified (Reddy and Busch,
1988; Massenet et al., 1998). Aside from 5
 
9
 
 cap trimethyla-
tion, numerous internal nucleotides are pseudouridylated
 
or 2
 
9
 
-
 
O
 
-methylated. U2 is the most extensively modified
of all the spliceosomal snRNAs. There are 10 2
 
9
 
-
 
O
 
-meth-
ylated residues and 13 pseudouridines in the 
 
Xenopus
 
 U2
snRNA (Fig. 1; Yu et al., 1998).
The biogenesis of U2 and the other spliceosomal sn-
RNPs has been extensively studied, principally using 
 
Xe-
nopus
 
 oocytes (Mattaj, 1988; Mattaj and Englmeier, 1998).
With the exception of U6, all major spliceosomal snRNAs
are transcribed by RNA polymerase (Pol) II in response
to specific promoter and termination signals (Dahlberg
and Lund, 1988). These Pol II transcripts are rapidly trans-
ported to the cytoplasm, where the RNAs are trimmed at
their 3
 
9
 
 ends and a common set of proteins called the
“core” Sm proteins are assembled onto the conserved Sm
binding sequence present in each of these snRNAs (Mat-
taj and De Robertis, 1985; Luhrmann, 1988). Upon bind-
ing of the Sm proteins, the 5
 
9
 
-monomethylated guanosine
cap becomes 2,2,7-trimethylated, an event that is sufficient
for recognition by the protein snurportin 1, which facili-
tates the transport of these RNA-protein particles back to
the nucleus (Huber et al., 1998). In addition to the com-
mon Sm proteins, each mature Sm snRNP contains spe-
cific proteins, the number of which varies between sn-
RNPs and can be quite large (Luhrmann, 1988; Behrens et
al., 1993; Gottschalk et al., 1998, 1999). Two distinct U2 sn-
RNPs have been observed in nuclear extracts from HeLa
cells (Behrens et al., 1993) and 
 
Xenopus
 
 oocytes (Yu et al.,
1998), corresponding to 12S or 17S particles. The 12S par-
ticle contains all the core Sm proteins and two U2-specific
proteins, whereas the 17S particle possesses at least nine
additional loosely associated U2-specific proteins (Beh-
rens et al., 1993). Seven of these nine proteins are the
subunits of splicing factor 3 (SF3; Krämer, 1996). Using
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microinjection into the 
 
Xenopus
 
 oocyte, we recently dem-
onstrated that the modified nucleotides within the 5
 
9
 
 27
nucleotides of U2 are essential for conversion of the 12S
particle to the mature 17S particle (Yu et al., 1998).
Although it is clear that U2 and other Sm snRNAs un-
dergo Sm protein binding and 5
 
9
 
 cap hypermethylation in
the cytoplasm, it is not known where within the cell these
Sm snRNAs are internally modified. It is established that
the nucleolus harbors a large number of small nucleolar
(sno)RNPs responsible for pseudouridylation and 2
 
9
 
-
 
O
 
-methylation of Pol I–transcribed ribosomal RNAs
(Maxwell and Fournier, 1995; Smith and Steitz, 1997; Tol-
lervey and Kiss, 1997; Yu et al., 1999). Recent studies indi-
cate that 2
 
9
 
-
 
O
 
-methylation of U6 snRNA, a Pol III tran-
script, is likewise mediated by snoRNPs (Tycowski et al.,
1998; Ganot et al., 1999). Intranuclear localization studies
indicate that the U6 snRNA travels through the nucleolus
(Lange and Gerbi, 2000; Narayanan, A., R.M. Terns, and
M.P. Terns, unpublished data). The striking similarities in
2
 
9
 
-
 
O
 
-methylation between ribosomal RNAs (rRNAs) and
the U6 snRNA raises the possibility that internal modifica-
tion of Pol II–transcribed U2 and other Sm snRNAs also
occurs in the nucleolus. In this study, we use the 
 
Xenopus
 
oocyte microinjection system to show that internal modifi-
cation of U2 (a product of Pol II transcription) occurs ex-
clusively in the nucleus, and likely within the nucleolus.
 
Materials and Methods
 
Preparation of U2 Mutant and Chimeric RNAs
 
PCR was used to generate the Sm-mutant U2 construct, starting with a
plasmid containing the wild-type U2 sequence (Yu et al., 1998). First, a 5
 
9
 
and a 3
 
9
 
 Sm-mutated U2 fragment were produced using two pairs of DNA
oligonucleotides. One pair (the 5
 
9
 
 primer [primer 1], 5
 
9
 
-TAATACGACT-
CACTATAG-3
 
9
 
, corresponding to the T7 promoter sequence located im-
mediately upstream of the 5
 
9
 
 terminus of U2, and the 3
 
9
 
 primer [primer 2],
5
 
9
 
-CCTGTTCCAACCATCCATTTAATATATGG-3
 
9
 
, complementary
to nucleotides 84–112 of 
 
Xenopus
 
 U2 except for two mismatches [under-
lined] in the second and third nucleotides of the Sm binding site) was used
 
to amplify a 5
 
9
 
 half U2 fragment. The other pair (the 5
 
9
 
 primer [primer 3],
5
 
9
 
-TAAATGGATGGTTGGAACAGGGAG-3
 
9
 
, corresponding to nu-
cleotides 92–115 of 
 
Xenopus
 
 U2, except for two changes in the second and
the third nucleotides of the Sm binding site [underlined], and the 3
 
9
 
primer [primer 4], 5
 
9
 
-GGGAAGTGCACCGGTCCTGGAGGT-3
 
9
 
, con-
taining three G’s 5
 
9
 
 to a 21–nucleotide sequence complementary to the 3
 
9
 
end of 
 
Xenopus
 
 U2) was used to create a 3
 
9
 
 half U2 fragment. These two
half DNA PCR products (containing an overlapping sequence, base pairs
92–112 with respect to the U2 sequence) were then mixed with primer 1
and primer 4 for a new round of PCR amplification, generating a mutant
U2 construct with the second and the third U’s of the Sm binding site
changed to G’s. The final PCR product was cloned into the SmaI site of
pGEM-3Z vector (Promega) and sequenced. After linearization with
SmaI, the plasmid was used as a template for GpppG-primed (for wild-
type U2, ApppG was also used) transcription by T7 RNA polymerase.
To generate U2-C/D motif chimeric RNAs, plasmids containing
the wild-type or the Sm-mutant U2 sequence were used as templates
for PCR. The 5
 
9
 
 primer, 5
 
9
 
-CCTAATACGACTCACTATAGGAT-
ATATATAATTTATGATCACGGTGATGAAATCGCTTCTCGGCC-
TTTTG-3
 
9
 
, corresponded to the T7 promoter sequence, the 5
 
9
 
 32 nucle-
otides of the yeast U14 snoRNA (including the terminal stem and box C
sequences [Samarsky et al., 1998]), and the 5
 
9 
 
19 nucleotides of U2. The 3
 
9
 
primer, 5
 
9
 
-ATATATATAGTATACGATCACTCAGACAAGTGCAC-
CGGTCCTGGAGG-3
 
9
 
, was complementary to the 3
 
9
 
 27 nucleotides of
yeast U14 (including the terminal stem and box D sequences) and the 3
 
9
 
20 nucleotides of 
 
Xenopus
 
 U2 RNA. After PCR, the DNA product was
gel purified and used as a template for in vitro T7 RNA polymerase tran-
scription.
To create the MID U2-U7 chimera, two oligodeoxynucleotides were
used. The 5
 
9
 
 primer, 5
 
9
 
-CCTAATACGACTCACTATAGGCTAAG-
ATCAAGTGTAGTATCTGTTCTCTATTTGTCTAGCAGG-3
 
9
 
, corre-
sponded to the T7 promoter sequence, nucleotides 19–46 of 
 
Xenopus
 
U2, and nucleotides 19–34 of 
 
Xenopus
 
 U7 snRNA. The 3
 
9
 
 primer, 5
 
9
 
-
TGTGGCTCCTACAGAGTAAGAACCTGCTAGACAAATAG-3
 
9
 
, was
complementary to the 3
 
9
 
 38 nucleotides of 
 
Xenopus
 
 U7 snRNA. These
two primers have a complementary sequence, nucleotides 19–34 with re-
spect to the 
 
Xenopus
 
 U7 snRNA. After annealing, both strands were ex-
tended with Klenow DNA polymerase. The double-stranded DNA prod-
uct served as a template for in vitro transcription of MID U2-U7 chimera
by T7 RNA polymerase.
 
Anti-Sm (Y12) Immunoprecipitation
 
Immunoprecipitation with anti-Sm (Y12) antibodies was performed ac-
cording to Lerner et al. (1981) and Yu et al. (1998). In brief, after injection
of labeled U2 RNAs, nuclei were broken by sonication in Net-2 buffer (50
Figure 1. Primary and secondary structure of Xenopus U2 snRNA. Internal modified nucleotides are highlighted by circles
(pseudouridines) and squares (29-O-methylated residues). The Sm binding site is indicated by a hatched gray box. Sequences known
or predicted to be involved in intermolecular interactions are indicated: the thick line denotes bases interacting with the branch site
of pre-mRNA; sequences boxed in dark gray, medium gray, and light gray are involved in U2-U6 interactions called Helix I, Helix II,
and Helix III, respectively (Nilsen, 1998). The arrows indicate mutations introduced into the Sm binding site (Sm-Mut). 
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mM Tris, pH 7.5, 150 mM NaCl, 0.05% NP-40). The nuclear suspension
was clarified by centrifugation at 14,000 
 
g
 
 for 5 min. The supernatant was
mixed with Y-12 antibodies at 4
 
8
 
C for 2 h. After centrifugation, the pellet
was washed three times with Net-2 buffer and digested with proteinase K.
RNAs were recovered by phenol-chloroform-isoamylalcohol extraction
and ethanol precipitation.
 
Xenopus Oocyte Microinjection and RNA
Modification Assays
 
The procedures for microinjection and modification assays were essen-
tially as described previously (Yu et al., 1998). In brief, various U2 RNAs
(differentially capped wild-type U2, Sm-mutant U2, U2-C/D motif chime-
ras, and the U2-U7 chimera) uniformly labeled with 
 
a
 
[
 
32
 
P]UTP (10
 
6
 
 cpm/
 
m
 
l) were individually injected into 
 
Xenopus
 
 oocytes (32 nl for cytoplasmic
injection, and 9 nl for nuclear injection [in most cases, 9 nl of U2 RNA
constructs was directly injected into isolated nuclei under oil]). After 5 h
at room temperature, RNAs were recovered from the nuclei or cytoplasm
and assayed for modifications.
To assay pseudouridylation, RNAs were digested with nuclease P1 in 3
 
m
 
l of 20 mM sodium acetate, pH 5.2, at 37
 
8
 
C for 1 h. The digested samples
were analyzed on cellulose TLC PEI plates (Baker; Patton, 1991). To de-
termine the site specificity of pseudouridylation, endogenous U2 was first
depleted from oocytes by cytoplasmic injection of an antisense U2 DNA
oligonucleotide complementary to nucleotides 28–42 of U2 (Yu et al.,
1998). Unlabeled U2 RNAs were then injected (
 
z
 
1 ng/oocyte). Recov-
ered RNAs were modified with 1-cyclohexyl-3-(2-morpholinoethyl)carbo-
diimide metho-
 
p
 
-toluenesulfonate (CMC), treated with sodium bicarbon-
ate buffer, pH 10.4, and analyzed by reverse transcription (Bakin and
Ofengand, 1993). Stops caused by pseudouridine-CMC modification were
visualized on 6% sequencing gels. To analyze pseudouridylation of U2-C/
D motif chimeras, a reverse transcription primer complementary to nucle-
otides 52–71 of U2 was used.
To assay 2
 
9
 
-
 
O
 
-methylation, labeled RNA preparations were site-specif-
ically cleaved by RNase H directed by 2
 
9
 
-
 
O
 
-methyl RNA–DNA chimeras
(5
 
9
 
-C
 
m
 
C
 
m
 
A
 
m
 
A
 
m
 
A
 
m
 
A
 
m
 
G
 
m
 
G
 
m
 
dCdCdGdAG
 
m
 
A
 
m
 
A
 
m
 
G
 
m
 
C
 
m
 
G
 
m
 
A
 
m
 
U
 
m
 
-3
 
9
 
, for
position 11 of U2, and 5
 
9
 
-A
 
m
 
C
 
m
 
A
 
m
 
dCdTdTdGA
 
m
 
U
 
m
 
C
 
m
 
U
 
m
 
U
 
m
 
A
 
m
 
G
 
m
 
C
 
m
 
-
C
 
m
 
A
 
m
 
A
 
m
 
A
 
m
 
A
 
m
 
-3
 
9
 
 for position 30 of U2). Cleaved and uncleaved U2
 
RNA constructs were analyzed on 6% denaturing gels (Yu et al., 1997,
1998).
 
Analysis of the Intranuclear Distribution of U2 snRNA 
and Variants
 
The procedure used to prepare Xenopus oocyte nuclear spreads and to
determine the intranuclear distrution of injected fluorescein-labeled
RNAs has been described (Narayanan et al., 1999). In brief, fluorescein-
labeled RNAs were generated by in vitro transcription of linearized plas-
mid DNA in the presence of a[32P]GTP and fluorescein-12-UTP (1:1 ratio
with UTP; Boehringer). The fluorescein-labeled RNAs (1 fmol each)
were injected into the nuclei of stage V or stage VI oocytes. 32P-labeled
U6 snRNA (retention control), U1 snRNA, and tRNA (export controls)
were coinjected with each fluorescein-labeled test RNA to help make con-
clusions about the stability and nucleocytoplasmic distribution of wild-
type U2 snRNA and U2 variants. The injected oocytes were incubated at
188C for 5 h before nuclei were dissected and nuclear spreads were pre-
pared. Images were obtained on a 633 magnification inverted fluores-
cence microscope (Axiovert S 100; ZEISS) equipped with differential
interference contrast (DIC) optics (Thornwood) using a cooled charge-
coupled device camera (Quantix-Photometrix) and IPLab Spectrum soft-
ware (Signal Analytics). Localization analysis was performed using multi-
ple independent sets of RNAs and oocytes, and at least four slides per
time point. Representative data are shown (see Fig. 4). To determine the
stability and nucleocytoplasmic distribution of the injected RNAs, RNAs
present in the nuclear (N) and cytoplasmic (C) fractions were purified 5 h
after injection (from the same set of oocytes analyzed by microscopy) and
analyzed by 8% denaturing PAGE and autoradiography.
Results
U2 Modification Occurs Exclusively in the Nucleus
Given the fact that U2 snRNA cycles through the cyto-
plasm before returning to the nucleus, we first tested
Figure 2. U2 internal modifi-
cations occur exclusively in the
nucleus.  a[32P]UTP uniformly
labeled G- or A-capped U2
was injected into the cytoplasm
of oocytes (A, lanes 1 and 2; B,
lanes 1–6) or directly into nuclei
(A, lanes 4 and 5; B, lanes 10–
15). After cytoplasmic injection,
only G-capped U2 entered the
nucleus; after nuclear injection,
both G- and A-capped U2
RNAs were retained in the nu-
cleus. RNAs recovered from
nuclei (A, lanes 1, 4, and 5; B,
lanes 1–3, 10–15) or from cyto-
plasm (A, lane 2; B, lanes 4–6)
were assayed for pseudouridyla-
tion (A) and 29-O-methylation
(B). In the 29-O-methylation as-
say, two different chimeras
were used to test two posi-
tions (G11 and A30). The
control is uninjected U2
RNA. (C) Oocyte nuclei were
separated from the cyto-
plasm under oil. a[32P]UTP
uniformly labeled U2 was
then injected into the isolated nuclei (lane 1) or enucleated oocytes (lane 2). After a 5-h incubation, U2 RNAs were recovered and as-
sayed for pseudouridylation. The positions of uridylate, pseudouridylate, uncleaved U2, and 39 fragments generated by RNase H site-
specific cleavage are indicated on the side of each gel. In these experiments, .80% of the expected level of pseudouridylation and 29-
O-methylation was observed.The Journal of Cell Biology, Volume 152, 2001 1282
whether the internal modification (pseudouridylation and
29-O-methylation) occurs in the nucleus and/or in the cyto-
plasm. In these experiments, we exploited the fact that
after injection into the cytoplasm of Xenopus oocytes,
GpppG-capped U2 is hypermethylated and rapidly trans-
ported into the nucleus, whereas ApppG-capped U2 is not
trimethylated and remains in the cytoplasm (Fischer et al.,
1991). 5 h after injection of differentially capped, uni-
formly  a[32P]UTP-labeled U2 snRNA into the cytoplasm,
the cytoplasm and the nucleus were manually separated.
The RNA in each cellular compartment was assayed for
pseudouridylation by complete nuclease P1 digestion fol-
lowed by TLC analysis (Fig. 2 A) and for 29-O-methyla-
tion by RNase H site-specific cleavage directed by 29-
O-methyl RNA–DNA chimeras (Fig. 2 B; Yu et al., 1997,
1998). The G-capped U2 recovered from nuclei was effi-
ciently pseudouridylated (Fig. 2 A, lane 1) and 29-O-meth-
ylated (Fig. 2 B, lanes 1–3). In contrast, the A-capped U2
recovered from the cytoplasm was not detectably modified
(Fig. 2, A and B, lanes 2 and 4–6, respectively). To ensure
that the cap structure does not affect the ability to serve as
a substrate for internal modification, we injected both
A-capped and G-capped U2 RNA directly into nuclei and
found that both were modified to a comparable extent
(Fig. 2 A, compare lanes 4 and 5, and 2 B, compare lanes
10–12 and 13–15).
To confirm these results, we physically separated oocyte
nuclei from the cytoplasm under oil (Lund and Paine,
1990) and then injected U2 snRNA containing either the
A or G cap directly into the isolated nuclei or the enu-
cleated oocytes. Again, only U2 RNA recovered from
isolated nuclei, not from the enucleated oocytes, was
pseudouridylated (Fig. 2 C, compare lanes 1 and 2) and 29-
O-methylated (data not shown). To ensure that the enu-
cleated oocytes were functional, we conducted anti-Sm
and anti–trimethyl guanosine cap immunoprecipitation
experiments. Our data showed that both G- and A-capped
U2 snRNAs injected into the cytoplasm were able to as-
semble into immunoprecipitable Sm snRNPs and that
G-capped U2 snRNA became 59 trimethylated (data not
shown). We conclude that pseudouridylation and 29-
O-methylation occur exclusively in the nucleus and do not
require prior 59 cap trimethylation.
The Sm Binding Site of U2 snRNA Is Required for 
Internal Modification
The Sm binding site is critical for U2 snRNP biogenesis
(Luhrmann, 1988; Mattaj, 1988) and is located in the 39
half of the RNA, where essentially no modified nucle-
otides are present. We mutated this element by changing
the second and the third uridines in the Sm binding site to
guanosines (Fig. 1). 5 h after injection of RNA that was
uniformly labeled with a[32P]UTP into isolated nuclei, to-
tal RNAs were recovered and modification assays were
performed. Although the wild-type U2 was pseudouridy-
lated (Fig. 3, lane 2) and 29-O-methylated (data not
shown), no modified nucleotides were detected in the Sm-
mutant RNA (Fig. 3, lane 3 and data not shown), even af-
ter a prolonged (10-h) incubation (Fig. 3, lane 7), suggest-
ing that the Sm site is required for internal modification.
The Sm site is important as a site for binding of Sm pro-
teins, which normally occurs in the cytoplasm; however,
assembly of the Sm RNP can occur in the nucleus under
some conditions, apparently via exchange of proteins with
endogenous snRNPs (Terns and Dahlberg, 1994; Terns et
al., 1995). Assembly of the injected wild-type U2 into par-
ticles in our experiments was confirmed by anti-Sm immu-
noprecipitation: z50% of injected RNAs were immuno-
precipitated (Fig. 3, compare lanes 4 and 5). The U2 RNA
bound by Sm proteins was pseudouridylated (Fig. 3, lane
5), whereas only a trace amount of pseudouridylate was
detected in the supernatant (unbound) fraction (Fig. 3,
lane 4), presumably because of incomplete immunoprecip-
itation. We conclude that the Sm binding site, and likely
the binding of Sm proteins, is required for U2 internal
modification.
Wild-Type U2, but Not Sm-mutant U2, Localizes to
the Nucleolus
The Sm binding site could contribute to U2 internal modi-
fication in several ways. For instance, mutation of the Sm
binding site could directly or indirectly impair recognition
of the snRNA by the modifying machinery. Alternatively,
the nucleus contains several subcompartments (e.g., nucleo-
plasm, nucleoli, Cajal bodies, gems, speckles, and snurpo-
somes) and the binding of Sm core proteins could target
the U2 snRNA to nuclear subcompartments where inter-
nal modification occurs. Alteration of the Sm binding site
resulting in mislocalization would thus affect modification.
We analyzed the intranuclear distribution of fluo-
rescently labeled RNAs to pinpoint the location of the
wild-type and the Sm-mutant U2 within the nucleus. Flu-
orescently and radio-labeled U2 RNAs, along with
radiolabeled control RNAs (U1 snRNA, U6 snRNA, and
tRNA), were injected into oocyte nuclei and the intranu-
Figure 3. Binding of Sm proteins is required for U2 internal
modification. [a32P]UTP uniformly labeled wild-type (lanes 2, 4,
5, and 6) or Sm-mutant U2 (lanes 3 and 7; see Fig. 1) was injected
into isolated nuclei under oil. After 5 h (lanes 1–5) or 10 h (lanes
6 and 7) at room temperature, RNAs were recovered by phenol-
chloroform-isoamylalcohol extraction and ethanol precipitation
and subjected to the pseudouridylation assay (lanes 1–3, 6, and 7).
For the wild-type U2, z40% (lane 2, 5 h) or 50% (lane 6, 10 h) of
the expected level of modification was observed. Alternatively,
wild-type U2 was recovered by anti-Sm (Y-12 antibody) immuno-
precipitation after 5 h at room temperature and then subjected to
the pseudouridylation assay (lanes 4 and 5). More than 85% of
the expected level of modification was observed in immuno-
precipitated RNA (lane 5). S, supernatant; P, pellet. The control
is an uninjected U2 RNA.Yu et al. U2 Internal Modification Occurs in Nucleoli 1283
clear distribution of U2 was analyzed by fluorescence mi-
croscopy of nuclear spreads prepared 5 h after injection
(Fig. 4 A). We also extracted the RNAs from the nucleus
and cytoplasm and analyzed their nucleocytoplasmic dis-
tribution and stability by gel electrophoresis (Fig. 4 B).
The wild-type U2 snRNA was localized to nucleoli and
Cajal bodies (Fig. 4 A, U2). The U2 nucleolar signal was
less than that observed for U65 snoRNA, but it was signif-
icantly greater than the level observed for U1 snRNA and
the background fluorescence of uninjected oocytes (Fig. 4
A, compare U2, U1, U65, and uninjected). In contrast, the
Sm-mutant U2 RNA was observed only in Cajal bodies;
Figure 4. (A) Intranuclear localization of wild-type U2 and Sm-
mutant U2 (U2sm2) snRNAs. 1 fmol of 32P- and fluorescently la-
beled, in vitro–transcribed U2, Sm-mutant U2, U1, or U65 was in-
jected into Xenopus oocyte nuclei. Nuclear spreads were prepared 5 h
later. U1 was included as a positive control for Cajal body localiza-
tion and as a negative control for nucleolar localization (Narayanan
et al., 1999). U65 snoRNA served as a positive control for nucleolar
localization and as a negative control for Cajal body localization
(Narayanan et al., 1999). A nuclear spread prepared from an unin-
jected oocyte was included to control for background fluorescence
of the preparations. The nuclear spreads were analyzed by DIC and
fluorescence (FL) microscopy. Each panel includes several nucleoli
and a few Cajal bodies. Cajal bodies are indicated by arrowheads in
the DIC panels. (B) Nucleocytoplasmic distribution of U2 and Sm-
mutant U2 (U2sm2) snRNAs. Injected oocytes from the same batch
analyzed above were dissected into nuclear and cytoplasmic frac-
tions after 5 h. Samples were analyzed by denaturing PAGE and au-
toradiography to determine the stability and nucleocytoplasmic dis-
tribution of the injected RNAs. tRNA was used as a positive control
for export and U6 served as a nuclear retention control (Narayanan
et al., 1999; Speckmann et al., 1999). Nuclear (N) RNAs are in lanes
2 and 5, cytoplasmic (C) RNAs are in lanes 3 and 6, and marker (M)
lanes 1 and 4 show RNAs before injection. Bar, 10 mm.
Figure 5. Introduction of a snoRNA nucleolar localization signal
restores internal modification of Sm-mutant U2. (A) Structures of
the wild-type U2-C/D motif chimera, the Sm-mutant U2-C/D motif
chimera, the 59 1/2U2-C/D motif chimera, the 39 1/2U2-C/D motif
chimera, and the 59 1/2U2-C/DDC motif chimera, each containing a
nucleolar localization signal derived from U14 snoRNA (box C,
box D, and a short terminal stem), are shown schematically. The
two arrows in the Sm-mutant U2-C/D chimera depict the double
point mutation in the Sm binding site. The two arrows in 59 1/2U2-
C/DDC indicate the sequence alterations in box C. (B) [a32P]UTP
uniformly labeled wild-type U2-C/D motif chimera (lane 2), Sm-
mutant U2-C/D motif chimera (lane 3), 59 1/2U2-C/D motif chimera
(lane 4), 39 1/2U2-C/D motif chimera (lane 5), or 59 1/2U2-C/DDC
motif chimera (lane 6) was injected into isolated nuclei under oil. 5 h
later, RNAs were recovered and assayed for modification. 40–50%
of the calculated level of modification was observed in lanes 2–4.
The positions of uridylate and pseudouridylate are indicated.The Journal of Cell Biology, Volume 152, 2001 1284
no signal was detected in nucleoli (Fig. 4 A, U2sm2). Con-
trol RNAs (U1, U6, and tRNA) behaved as expected (Fig.
4 B). The correlation between nucleolar localization and
efficient modification suggests that U2 internal modifica-
tions take place in the nucleolus.
Nucleolar Targeting of Sm-mutant U2 Restores 
Internal Modification
The observation that a double point mutation in the Sm
binding site resulted both in a loss of nucleolar localization
and internal modification of U2 RNA (Sm-mutant U2)
prompted us to test whether targeting of this RNA to nu-
cleoli can restore internal modification. Therefore, we in-
troduced a well-characterized nucleolar localization signal,
the snoRNA Box C/D motif (containing boxes C and D
and the terminal stem; Samarsky et al., 1998; Narayanan et
al., 1999; Speckmann et al., 1999), into Sm-mutant U2 as
well as into wild-type U2 RNA. Specifically, the 59-termi-
nal sequence of U14 snoRNA, including box C and one
strand of the terminal stem, was fused to the 59 terminus of
U2, while the 39-terminal sequence of U14, including box
D and the other strand of the terminal stem, was linked to
the 39 terminus of U2 (Fig. 5 A). In addition, the 59 half
(nucleotides 1–100) and the 39 half (101–188) of U2 were
each inserted into the same box C/D motif (Fig. 5 A).
These chimeric RNAs were injected into isolated nuclei,
incubated for 5 h, and assayed for modification.
Remarkably, the Sm-mutant U2-C/D motif chimera not
only became modified (Fig. 5 B, lane 3), but was modified
to a level equivalent to that of the wild-type U2-C/D motif
chimera (Fig. 5 B, lane 2). As expected, since all the inter-
nally modified nucleotides are located exclusively in the 59
half of U2, the 59 half U2-C/D motif chimera was effi-
ciently modified (lane 4). No modification was detected in
the 39 half U2-C/D motif chimera (lane 5). Modification
was dependent on the C/D motif, as changes in the box el-
ements completely abolished modification (lane 6, and
data not shown). The accuracy of the restored modifica-
tions was confirmed by RNase H site-specific cleavage di-
rected by 29-O-methyl RNA–DNA chimeras (for 29-meth-
ylation; Yu et al., 1997, 1998) and by CMC modification
followed by reverse transcription (for pseudouridylation,
see Materials and Methods; Bakin and Ofengand, 1993;
data not shown).
Visual evidence of nucleolar localization conferred on
these chimeric RNAs by the box C/D motif was obtained
by fluorescence microscopy using nuclear spreads prepared
5 h after injection of fluorescently labeled chimeric RNAs
into oocyte nuclei. Fig. 6 shows that introduction of the C/D
motif indeed resulted in targeting of the Sm-mutant U2-
C/D motif chimera and the 59 half U2-C/D motif chimera
to nucleoli (U2sm2-CD and 59 half U2-CD). The nucleolar
localization of these chimeric RNAs was dependent on the
presence of the C/D motif, as point mutations within the
motif resulted in loss of localization to nucleoli but not Ca-
jal bodies (Fig. 6, 59 half U2-CDDC). Introduction of the
C/D motif into wild-type U2 did not alter its nucleolar tar-
geting (compare Fig. 6, U2-CD and Fig. 4 A, U2).
Although our observations suggest that the nucleolus is
the site of U2 internal modification, U2 constructs that be-
come efficiently modified are detected in both nucleoli
and Cajal bodies. We attempted to assess any potential
role of Cajal bodies in modification by fusing a 59 fragment
(nucleotides 19–46) of U2 RNA to a 39 half sequence of
U7 snRNA, which contains a distinct Sm binding site
known to target U7 snRNAs to Cajal bodies (Wu et al.,
1996). Surprisingly, this U2-U7 chimera became modified
(Fig. 7 A, lane 3). As expected, the RNA localized to Cajal
bodies (Fig. 7 B, MIDU2-U7). However, we also detected
nucleolar signals that were weak but distinctly greater
than background, suggesting that these U2-U7 chimeric
constructs may transiently cycle through nucleoli for mod-
ification (see Discussion).
Discussion
Using the Xenopus oocyte microinjection system, we have
demonstrated that U2 internal modification is a nuclear
event. A combination of mutant analyses and fluorescence
microscopy further showed that efficiently modified U2
RNA variants are localized to nucleoli (and Cajal bodies),
Figure 6. (A) Intranuclear localization of U2-C/D motif chimeras.
1 fmol of fluorescein-labeled wild-type U2-C/D motif chimera
(U21CD), Sm-mutant U2-C/D motif chimera (U2sm2-CD), 59
1/2U2-C/D motif chimera (59 1/2U2-CD), or 59 1/2U2-C/DDC
motif chimera (59 1/2U21CDDC) was injected into Xenopus
oocyte nuclei, and nuclear spreads were prepared 5 h later.
DIC and fluorescence (FL) panels are shown for each field.
The arrowheads in the DIC panels indicate Cajal bodies. (B)
Nucleocytoplasmic distribution of the U2-C/D motif chimeras.
The distribution of the injected RNAs within the nuclear and
cytoplasmic oocyte compartments was determined as described
in the legend to Fig. 4 B. Bar, 10 mm.Yu et al. U2 Internal Modification Occurs in Nucleoli 1285
but that RNAs that are not localized to nucleoli are not
modified. Strikingly, a modification-deficient Sm-mutant
U2 RNA can be converted to a modification proficient
state by addition of an exogenous nucleolar localization
signal (the box C/D motif). Our findings suggest that U2
internal modifications occur in the nucleolus.
Previous studies suggested that U2 internal modification
might not occur in the nucleolus. Ganot et al. (1999) re-
ported that a fragment of U2 was not modified when fused
to an rRNA minigene and transcribed by RNA Pol I in the
nucleolus. Although the studies were done using a differ-
ent cell system (mouse versus Xenopus oocytes), two addi-
tional points should be considered. First, it is possible that
the short U2 sequence (22 nucleotides), fused to a large
rRNA sequence, formed a structure that prevented U2
from being accessed by the modifying machinery. Second,
modification of U2 may require prior exposure to other
nuclear environments, which might be forfeited when the
RNA is synthesized in the nucleolus. In our experiments
RNAs were injected into nuclei of oocytes, which may al-
low trafficking of the RNA in the nucleus and association
with relevant nuclear factors or structures. In other work it
was shown that pseudouridylation of position 44 of yeast
U2 snRNA can be catalyzed by a yeast tRNA pseudo-
uridylase, Pus1p (Massenet et al., 1999), which resides in
the nucleoplasm (Simos et al., 1996). Several other known
yeast pseudouridylases, including Cbf5p (NAP57), were
tested and found to be negative (Massenet et al., 1999),
suggesting that pseudouridylation of this site is not medi-
ated by snoRNPs in the nucleolus in yeast. It is possible
that internal modification of yeast Sm snRNAs is different
from that of vertebrate Sm snRNAs and that modification
of the other residues of yeast Sm snRNAs is catalyzed by
snoRNPs in the nucleolus.
Do Cajal Bodies as Well as Nucleoli Harbor Machinery 
for Internal Modification of U2?
U7 snRNA is targeted to Cajal bodies by its Sm site (Wu
et al., 1996), but is not detected in nucleoli (Fig. 7 C; Wu
et al., 1996). We were surprised to find that when attached
Figure 7. (A) Structures of Xenopus wild-type U7 snRNA and MIDU2-U7 chimera are shown schematically. The U7 Sm binding site
is indicated by a hatched box. Thin lines represent the U7 RNA chain. In the MID U2-U7 chimera, the first 18 nucleotides of U7 are
substituted with a Xenopus U2 sequence (nucleotides 19–46) indicated by a thicker line. (B) The U7 Sm binding site also supports U2
internal modification. [a32P]UTP uniformly labeled wild-type U7 (lane 1), U2-U7 chimera (MID U2-U7; lane 2), or wild-type U2 (lane
3) was injected into isolated nuclei under oil. 5 h later, RNAs were recovered and assayed for modification. The positions of uridylate
and pseudouridylate are indicated. (C) Intranuclear localization of U7 and the U2-U7 chimera. 32P- and fluorescently labeled wild-type
U7 and MID U2-U7 chimera were synthesized by in vitro transcription and 1 fmol of each RNA was microinjected into the nuclei of
Xenopus oocytes. Nuclei were isolated 5 h later and nuclear spreads were prepared. Spreads were also prepared from uninjected oo-
cytes as controls. DIC and fluorescence (FL) images are shown for each field. The arrowheads in the DIC panels point to Cajal bodies.
Prominent Cajal body labeling was observed for both U7 and the MID U2-U7 chimera. Weak but above background nucleolar signal
was also detected for the MID U2-U7 chimera. (D) The nucleocytoplasmic distribution of U7 and the U2-U7 chimera RNAs was deter-
mined as described in the legend to Fig. 4 B. Bar, 10 mm.The Journal of Cell Biology, Volume 152, 2001 1286
to the U7 Sm binding site, a 59 fragment of U2 was effi-
ciently modified (Fig. 7, A and B). The U2-U7 chimera
was targeted to Cajal bodies, but distinct nucleolar signals
were also observed (Fig. 7 C). We favor the explanation
that the U2-U7 chimeras are modified during a transient
association with nucleoli. The work of several labs sug-
gests that many types of RNAs progress through nucleoli
and Cajal bodies during their maturation, even if they ulti-
mately come to reside in other cellular subcompartments
(Pederson, 1998; for review see Olson et al., 2000). For in-
stance, box C/D snoRNAs, including U3, U8, and U14,
transiently associate with Cajal bodies before localization
to nucleoli (Narayanan et al., 1999; Speckmann et al.,
1999). On the other hand, U6 snRNA transiently localizes
to nucleoli, (Lange and Gerbi, 2000; Lukowiak, A. Naray-
anan, R.M. Terns, and M.P. Terns, manuscript submitted
for publication) presumably for modification mediated by
box C/D snoRNAs (Tycowski et al., 1998; Ganot et al.,
1999). Fibrillarin and NAP57, which are the presumed 29-
O-methylase and pseudouridine synthase components of
the box C/D and box H/ACA snoRNPs, respectively, have
been reported to be present in both nucleoli and Cajal
bodies (Raska et al., 1991; Meier and Blobel, 1994; Gall et
al., 1999). The Lamond group has also shown that mam-
malian spliceosomal snRNPs accumulate in Cajal bodies,
which, after treatment with a phosphatase inhibitor, coa-
lesce with nucleoli (Lyon et al., 1997; Sleeman et al., 1998).
The accumulation of spliceosomal snRNPs in Cajal bodies
and nucleoli is a transient event that occurs before local-
ization to speckles (Sleeman and Lamond, 1999), suggest-
ing that Cajal bodies and/or nucleoli may be the site(s)
for spliceosomal snRNA modification (Bohmann et al.,
1995a,b; Sleeman and Lamond, 1999). Our data indicate
that internal modification of U2 snRNA occurs in the nu-
cleolus, but does not exclude a role for Cajal bodies. Fur-
ther analyses are needed to establish whether U2 internal
modification also takes place within Cajal bodies.
Role of the Sm Binding Site in Intranuclear Trafficking
We have shown that the Sm binding site is required not
only for U2 internal modification but also for nucleolar lo-
calization. A double point mutation in the U2 Sm binding
site results in a modification defective phenotype and dis-
ruption of nucleolar targeting, even though a significant
fraction of the RNA remained in nuclei (including Cajal
bodies) at the time analyzed (Fig. 4). This observation sug-
gests a role for the Sm binding site in nucleolar targeting.
Interestingly however, two other Sm snRNAs, U1 and
U7, were detected in Cajal bodies but not nucleoli (Figs. 4
and 7). Why do these two Sm RNAs have different intra-
nuclear localization profiles? If U2 is internally modified
in the nucleolus, where are U1 and U7 modified? One ex-
planation is that U1 and U7 may pass through nucleoli too
quickly to generate detectable signals. The different nucle-
olar transit times of the RNAs could correlate with the
number of modifications acquired by the various RNAs.
U2 is modified at 23 internal sites (by pseudouridylation
and 29-O-methylation; Massenet et al., 1998; Reddy and
Busch, 1988) and is detected in the nucleolus (Fig. 4),
whereas U1 is modified at only five sites (Reddy and
Busch, 1988; Massenet et al., 1998) and is not detected
there (Fig 4). Similarly, U7 snRNA contains no pseudo-
uridylation (Fig. 7 B, lane 1) (it is unknown whether U7 is
29-O-methylated) and is not detected in the nucleolus. In-
terestingly, we also detect a transient nucleolar localiza-
tion of U6 snRNA (Lukowiak, A. Narayanan, R.M. Terns,
and M.P. Terns, manuscript submitted for publication),
which contains 13 internal modifications (Reddy and
Busch, 1988). Finally, addition of a 59 fragment (nucle-
otides 19–46) of U2, which lacks an Sm site but contains 10
sites of modification, to U7, which is not detected in nucle-
oli, results in detectable levels of nucleolar localization
(Fig. 7; U2-U7). Alternatively, differences in nucleolar
transit time may be a result of functional differences be-
tween the Sm binding sites. Comparing sites from various
species, we note a striking difference in the sequences for
U1 and U7 versus U2: AUUUGUG for U1 (AUUUCUG
in frog), AUUUGUC for U7, and AUUUUUG for U2.
Perhaps a difference in the fifth position of the Sm site me-
diates association with distinct factors that affect nucleolar
trafficking rates. Interestingly, the Sm binding sites of U1
and U5 (AUUUUUUG, more similar to U2 than to U1
and U7 Sm binding sites) are not functionally exchange-
able in protein binding (Jarmolowski and Mattaj, 1993).
Even between U1 and U7, the Sm binding sites are not ex-
changeable, since replacement of the U7 Sm site with the
U1 Sm site generates a nonfunctional U7 snRNP (Ste-
fanovic et al., 1995). Further studies are required to under-
stand the detailed differences between the functions of
various Sm binding sites. Our work indicates that the Sm
site targets U2 to nucleoli where it is modified. Other sn-
RNAs may transit through nucleoli with different kinetics.
At What Stage in U2 Biogenesis Does
Modification Occur?
Although our results demonstrate that U2 internal modifi-
cation occurs in the nucleus rather than the cytoplasm, we
still have no definitive answer to the question of whether
modifications are introduced before export to the cyto-
plasm or after reentry into the nucleus. For three reasons,
we consider the latter more likely. First, it is well estab-
lished that the Sm snRNAs are rapidly transported to the
cytoplasm after synthesis in the nucleus (Yang et al., 1992;
Terns et al., 1993; Jarmolowski et al., 1994). By contrast,
U2 internal modification is relatively slow, in our hands re-
quiring more than 6 h to complete (Yu et al., 1998; data not
shown). Second, we have shown previously that internal
modifications directly contribute to the conversion of the
12S U2 particle into the functional 17S particle, which pos-
sesses at least nine extra proteins (Behrens et al., 1993).
This suggests that the internal modifications are intro-
duced at the stage between 12S and 17S snRNP assembly,
i.e., after U2 transport back to the nucleus. Third, we have
demonstrated here that an intact Sm site, and presumably
the binding of Sm proteins, is required for U2 internal
modification (Fig. 3). Since assembly with Sm proteins nor-
mally occurs in the cytoplasm (Mattaj, 1988), internal mod-
ification could occur only after reentry into the nucleus.
Is Internal Modification of Sm snRNAs Guided by 
snoRNAs in the Nucleolus?
Our evidence that U2 internal modification occurs in the
nucleolus strongly supports the notion that the nucleolusYu et al. U2 Internal Modification Occurs in Nucleoli 1287
harbors the modifying machinery responsible for pseudo-
uridylation and 29-O-methylation of several different types
of RNAs. These include ribosomal RNAs (Pol I tran-
scripts; Cavaille et al., 1996; Kiss-Laszlo et al., 1996, 1998;
Ganot et al., 1997; Ni et al., 1997; Bortolin et al., 1999), U6
snRNA (a Pol III transcript; Tycowski et al., 1998; Ganot
et al., 1999; Lange and Gerbi, 2000), and U2 and perhaps
other Sm snRNAs (Pol II transcripts; this study). Modifi-
cation of eukaryotic rRNAs and U6 snRNA is catalyzed
by snoRNPs, where the snoRNA component serves as a
guide to direct modification at a specific site (Cavaille et
al., 1996; Kiss-Laszlo et al., 1996, 1998; Ganot et al., 1997,
1999; Ni et al., 1997; Tycowski et al., 1998; Bortolin et al.,
1999). Are the Pol II–transcribed Sm snRNAs (U2 and
others) modified by the same mechanism? Since all of
these RNAs share a common modification subcompart-
ment, the nucleolus, we predict the existence of similar
snoRNPs responsible for internal modification (29-O-meth-
ylation and pseudouridylation) of Pol II–transcribed Sm
snRNAs.
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